Syndax to Announce Third Quarter 2026 Financial Results and Host Conference Call and Webcast on November 2, 2026
Globe Newswire•26/10/2026•07:00 ET
0
Key Highlights
- ➤Syndax will report third-quarter 2026 financial results November 2, 2026
- ➤Management will provide a business update during the November 2 conference call
- ➤Syndax’s pipeline includes FDA-approved Revuforj and Niktimvo cancer therapies
NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that it will report its third quarter 2026 financial results and provide a business update on Monday, November 2, 2026.
In connection with the earnings release, Syndax's management will host a conference call and live audio webcast at 4:30 p.m. ET on Monday, November 2, 2026.
Get started
Create a free account to read the full story.